| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $629.1M | +22.0% |
| Cost of Revenue | $275.3M | +16.6% |
| Gross Profit | $353.8M | +26.5% |
| R&D Expense | $104.6M | +58.2% |
| SG&A Expense | $99.1M | +53.8% |
| Operating Income | -$151.2M | -94.1% |
| Pre-tax Income | -$151.6M | -92.3% |
| Income Tax | $2.3M | +93.2% |
| Net Income | -$153.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $313.7M | -41.2% |
| Short-term Investments | $151.7M | — |
| Accounts Receivable | $104.5M | +42.8% |
| Current Assets | $615.0M | -4.2% |
| Total Assets | $737.6M | -0.3% |
| Current Liabilities | $386.9M | +13.3% |
| Total Liabilities | $398.3M | +13.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$61.0M | -758.1% |
| Capital Expenditures | $1.6M | -70.7% |
| Investing Cash Flow | -$173.2M | -228.7% |
| Financing Cash Flow | $14.8M | -96.5% |
| Free Cash Flow | -$62.5M | -402.6% |
| -92.3% |
| EPS (Basic) | -$1.09 | +25.3% |
| EPS (Diluted) | -$1.09 | +25.3% |
| Stockholders' Equity |
| $339.3M |
| -12.9% |